COVID-19 Impact on Global Peptide APIs Market Insights, Forecast to 2026
Peptide APIs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide APIs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Peptide APIs market is segmented into
The Peptide APIs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peptide APIs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptide APIs Market Share Analysis
Peptide APIs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptide APIs business, the date to enter into the Peptide APIs market, Peptide APIs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Peptide APIs market is segmented into
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Cancer
- Diabetes
- Obesity
- Fertility
- Other
The Peptide APIs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peptide APIs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptide APIs Market Share Analysis
Peptide APIs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptide APIs business, the date to enter into the Peptide APIs market, Peptide APIs product introduction, recent developments, etc.
The major vendors covered:
- CordenPharma
- PolyPeptide
- Bachem
- AmbioPharm
- Pepscan
- BCN Peptides
- Senn Chemicals
1 STUDY COVERAGE
1.1 Peptide APIs Product Introduction
1.2 Market Segments
1.3 Key Peptide APIs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Peptide APIs Market Size Growth Rate by Type
1.4.2 Liquid Phase Peptide Synthesis (LPPS)
1.4.3 Solid Phase Peptide Synthesis (SPPS)
1.5 Market by Application
1.5.1 Global Peptide APIs Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Obesity
1.5.5 Fertility
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Peptide APIs Industry Impact
1.6.1 How the Covid-19 is Affecting the Peptide APIs Industry
1.6.1.1 Peptide APIs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Peptide APIs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Peptide APIs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Peptide APIs Market Size Estimates and Forecasts
2.1.1 Global Peptide APIs Revenue 2015-2026
2.1.2 Global Peptide APIs Sales 2015-2026
2.2 Peptide APIs Market Size by Region: 2020 Versus 2026
2.2.1 Global Peptide APIs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Peptide APIs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PEPTIDE APIS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Peptide APIs Sales by Manufacturers
3.1.1 Peptide APIs Sales by Manufacturers (2015-2020)
3.1.2 Peptide APIs Sales Market Share by Manufacturers (2015-2020)
3.2 Peptide APIs Revenue by Manufacturers
3.2.1 Peptide APIs Revenue by Manufacturers (2015-2020)
3.2.2 Peptide APIs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peptide APIs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Peptide APIs Revenue in 2019
3.2.5 Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Peptide APIs Price by Manufacturers
3.4 Peptide APIs Manufacturing Base Distribution, Product Types
3.4.1 Peptide APIs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptide APIs Product Type
3.4.3 Date of International Manufacturers Enter into Peptide APIs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Peptide APIs Market Size by Type (2015-2020)
4.1.1 Global Peptide APIs Sales by Type (2015-2020)
4.1.2 Global Peptide APIs Revenue by Type (2015-2020)
4.1.3 Peptide APIs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Peptide APIs Market Size Forecast by Type (2021-2026)
4.2.1 Global Peptide APIs Sales Forecast by Type (2021-2026)
4.2.2 Global Peptide APIs Revenue Forecast by Type (2021-2026)
4.2.3 Peptide APIs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Peptide APIs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Peptide APIs Market Size by Application (2015-2020)
5.1.1 Global Peptide APIs Sales by Application (2015-2020)
5.1.2 Global Peptide APIs Revenue by Application (2015-2020)
5.1.3 Peptide APIs Price by Application (2015-2020)
5.2 Peptide APIs Market Size Forecast by Application (2021-2026)
5.2.1 Global Peptide APIs Sales Forecast by Application (2021-2026)
5.2.2 Global Peptide APIs Revenue Forecast by Application (2021-2026)
5.2.3 Global Peptide APIs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Peptide APIs by Country
6.1.1 North America Peptide APIs Sales by Country
6.1.2 North America Peptide APIs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Peptide APIs Market Facts & Figures by Type
6.3 North America Peptide APIs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Peptide APIs by Country
7.1.1 Europe Peptide APIs Sales by Country
7.1.2 Europe Peptide APIs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptide APIs Market Facts & Figures by Type
7.3 Europe Peptide APIs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Peptide APIs by Region
8.1.1 Asia Pacific Peptide APIs Sales by Region
8.1.2 Asia Pacific Peptide APIs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Peptide APIs Market Facts & Figures by Type
8.3 Asia Pacific Peptide APIs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Peptide APIs by Country
9.1.1 Latin America Peptide APIs Sales by Country
9.1.2 Latin America Peptide APIs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Peptide APIs Market Facts & Figures by Type
9.3 Central & South America Peptide APIs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Peptide APIs by Country
10.1.1 Middle East and Africa Peptide APIs Sales by Country
10.1.2 Middle East and Africa Peptide APIs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Peptide APIs Market Facts & Figures by Type
10.3 Middle East and Africa Peptide APIs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 CordenPharma
11.1.1 CordenPharma Corporation Information
11.1.2 CordenPharma Description, Business Overview and Total Revenue
11.1.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CordenPharma Peptide APIs Products Offered
11.1.5 CordenPharma Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Corporation Information
11.2.2 PolyPeptide Description, Business Overview and Total Revenue
11.2.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PolyPeptide Peptide APIs Products Offered
11.2.5 PolyPeptide Recent Development
11.3 Bachem
11.3.1 Bachem Corporation Information
11.3.2 Bachem Description, Business Overview and Total Revenue
11.3.3 Bachem Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bachem Peptide APIs Products Offered
11.3.5 Bachem Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Corporation Information
11.4.2 AmbioPharm Description, Business Overview and Total Revenue
11.4.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AmbioPharm Peptide APIs Products Offered
11.4.5 AmbioPharm Recent Development
11.5 Pepscan
11.5.1 Pepscan Corporation Information
11.5.2 Pepscan Description, Business Overview and Total Revenue
11.5.3 Pepscan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pepscan Peptide APIs Products Offered
11.5.5 Pepscan Recent Development
11.6 BCN Peptides
11.6.1 BCN Peptides Corporation Information
11.6.2 BCN Peptides Description, Business Overview and Total Revenue
11.6.3 BCN Peptides Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BCN Peptides Peptide APIs Products Offered
11.6.5 BCN Peptides Recent Development
11.7 Senn Chemicals
11.7.1 Senn Chemicals Corporation Information
11.7.2 Senn Chemicals Description, Business Overview and Total Revenue
11.7.3 Senn Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Senn Chemicals Peptide APIs Products Offered
11.7.5 Senn Chemicals Recent Development
11.1 CordenPharma
11.1.1 CordenPharma Corporation Information
11.1.2 CordenPharma Description, Business Overview and Total Revenue
11.1.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CordenPharma Peptide APIs Products Offered
11.1.5 CordenPharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Peptide APIs Market Estimates and Projections by Region
12.1.1 Global Peptide APIs Sales Forecast by Regions 2021-2026
12.1.2 Global Peptide APIs Revenue Forecast by Regions 2021-2026
12.2 North America Peptide APIs Market Size Forecast (2021-2026)
12.2.1 North America: Peptide APIs Sales Forecast (2021-2026)
12.2.2 North America: Peptide APIs Revenue Forecast (2021-2026)
12.2.3 North America: Peptide APIs Market Size Forecast by Country (2021-2026)
12.3 Europe Peptide APIs Market Size Forecast (2021-2026)
12.3.1 Europe: Peptide APIs Sales Forecast (2021-2026)
12.3.2 Europe: Peptide APIs Revenue Forecast (2021-2026)
12.3.3 Europe: Peptide APIs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Peptide APIs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Peptide APIs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Peptide APIs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Peptide APIs Market Size Forecast by Region (2021-2026)
12.5 Latin America Peptide APIs Market Size Forecast (2021-2026)
12.5.1 Latin America: Peptide APIs Sales Forecast (2021-2026)
12.5.2 Latin America: Peptide APIs Revenue Forecast (2021-2026)
12.5.3 Latin America: Peptide APIs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Peptide APIs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Peptide APIs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Peptide APIs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Peptide APIs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Peptide APIs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Peptide APIs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Peptide APIs Product Introduction
1.2 Market Segments
1.3 Key Peptide APIs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Peptide APIs Market Size Growth Rate by Type
1.4.2 Liquid Phase Peptide Synthesis (LPPS)
1.4.3 Solid Phase Peptide Synthesis (SPPS)
1.5 Market by Application
1.5.1 Global Peptide APIs Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Obesity
1.5.5 Fertility
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Peptide APIs Industry Impact
1.6.1 How the Covid-19 is Affecting the Peptide APIs Industry
1.6.1.1 Peptide APIs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Peptide APIs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Peptide APIs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Peptide APIs Market Size Estimates and Forecasts
2.1.1 Global Peptide APIs Revenue 2015-2026
2.1.2 Global Peptide APIs Sales 2015-2026
2.2 Peptide APIs Market Size by Region: 2020 Versus 2026
2.2.1 Global Peptide APIs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Peptide APIs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PEPTIDE APIS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Peptide APIs Sales by Manufacturers
3.1.1 Peptide APIs Sales by Manufacturers (2015-2020)
3.1.2 Peptide APIs Sales Market Share by Manufacturers (2015-2020)
3.2 Peptide APIs Revenue by Manufacturers
3.2.1 Peptide APIs Revenue by Manufacturers (2015-2020)
3.2.2 Peptide APIs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peptide APIs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Peptide APIs Revenue in 2019
3.2.5 Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Peptide APIs Price by Manufacturers
3.4 Peptide APIs Manufacturing Base Distribution, Product Types
3.4.1 Peptide APIs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptide APIs Product Type
3.4.3 Date of International Manufacturers Enter into Peptide APIs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Peptide APIs Market Size by Type (2015-2020)
4.1.1 Global Peptide APIs Sales by Type (2015-2020)
4.1.2 Global Peptide APIs Revenue by Type (2015-2020)
4.1.3 Peptide APIs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Peptide APIs Market Size Forecast by Type (2021-2026)
4.2.1 Global Peptide APIs Sales Forecast by Type (2021-2026)
4.2.2 Global Peptide APIs Revenue Forecast by Type (2021-2026)
4.2.3 Peptide APIs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Peptide APIs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Peptide APIs Market Size by Application (2015-2020)
5.1.1 Global Peptide APIs Sales by Application (2015-2020)
5.1.2 Global Peptide APIs Revenue by Application (2015-2020)
5.1.3 Peptide APIs Price by Application (2015-2020)
5.2 Peptide APIs Market Size Forecast by Application (2021-2026)
5.2.1 Global Peptide APIs Sales Forecast by Application (2021-2026)
5.2.2 Global Peptide APIs Revenue Forecast by Application (2021-2026)
5.2.3 Global Peptide APIs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Peptide APIs by Country
6.1.1 North America Peptide APIs Sales by Country
6.1.2 North America Peptide APIs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Peptide APIs Market Facts & Figures by Type
6.3 North America Peptide APIs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Peptide APIs by Country
7.1.1 Europe Peptide APIs Sales by Country
7.1.2 Europe Peptide APIs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptide APIs Market Facts & Figures by Type
7.3 Europe Peptide APIs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Peptide APIs by Region
8.1.1 Asia Pacific Peptide APIs Sales by Region
8.1.2 Asia Pacific Peptide APIs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Peptide APIs Market Facts & Figures by Type
8.3 Asia Pacific Peptide APIs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Peptide APIs by Country
9.1.1 Latin America Peptide APIs Sales by Country
9.1.2 Latin America Peptide APIs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Peptide APIs Market Facts & Figures by Type
9.3 Central & South America Peptide APIs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Peptide APIs by Country
10.1.1 Middle East and Africa Peptide APIs Sales by Country
10.1.2 Middle East and Africa Peptide APIs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Peptide APIs Market Facts & Figures by Type
10.3 Middle East and Africa Peptide APIs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 CordenPharma
11.1.1 CordenPharma Corporation Information
11.1.2 CordenPharma Description, Business Overview and Total Revenue
11.1.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CordenPharma Peptide APIs Products Offered
11.1.5 CordenPharma Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Corporation Information
11.2.2 PolyPeptide Description, Business Overview and Total Revenue
11.2.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PolyPeptide Peptide APIs Products Offered
11.2.5 PolyPeptide Recent Development
11.3 Bachem
11.3.1 Bachem Corporation Information
11.3.2 Bachem Description, Business Overview and Total Revenue
11.3.3 Bachem Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bachem Peptide APIs Products Offered
11.3.5 Bachem Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Corporation Information
11.4.2 AmbioPharm Description, Business Overview and Total Revenue
11.4.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AmbioPharm Peptide APIs Products Offered
11.4.5 AmbioPharm Recent Development
11.5 Pepscan
11.5.1 Pepscan Corporation Information
11.5.2 Pepscan Description, Business Overview and Total Revenue
11.5.3 Pepscan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pepscan Peptide APIs Products Offered
11.5.5 Pepscan Recent Development
11.6 BCN Peptides
11.6.1 BCN Peptides Corporation Information
11.6.2 BCN Peptides Description, Business Overview and Total Revenue
11.6.3 BCN Peptides Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BCN Peptides Peptide APIs Products Offered
11.6.5 BCN Peptides Recent Development
11.7 Senn Chemicals
11.7.1 Senn Chemicals Corporation Information
11.7.2 Senn Chemicals Description, Business Overview and Total Revenue
11.7.3 Senn Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Senn Chemicals Peptide APIs Products Offered
11.7.5 Senn Chemicals Recent Development
11.1 CordenPharma
11.1.1 CordenPharma Corporation Information
11.1.2 CordenPharma Description, Business Overview and Total Revenue
11.1.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CordenPharma Peptide APIs Products Offered
11.1.5 CordenPharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Peptide APIs Market Estimates and Projections by Region
12.1.1 Global Peptide APIs Sales Forecast by Regions 2021-2026
12.1.2 Global Peptide APIs Revenue Forecast by Regions 2021-2026
12.2 North America Peptide APIs Market Size Forecast (2021-2026)
12.2.1 North America: Peptide APIs Sales Forecast (2021-2026)
12.2.2 North America: Peptide APIs Revenue Forecast (2021-2026)
12.2.3 North America: Peptide APIs Market Size Forecast by Country (2021-2026)
12.3 Europe Peptide APIs Market Size Forecast (2021-2026)
12.3.1 Europe: Peptide APIs Sales Forecast (2021-2026)
12.3.2 Europe: Peptide APIs Revenue Forecast (2021-2026)
12.3.3 Europe: Peptide APIs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Peptide APIs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Peptide APIs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Peptide APIs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Peptide APIs Market Size Forecast by Region (2021-2026)
12.5 Latin America Peptide APIs Market Size Forecast (2021-2026)
12.5.1 Latin America: Peptide APIs Sales Forecast (2021-2026)
12.5.2 Latin America: Peptide APIs Revenue Forecast (2021-2026)
12.5.3 Latin America: Peptide APIs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Peptide APIs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Peptide APIs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Peptide APIs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Peptide APIs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Peptide APIs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Peptide APIs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Peptide APIs Market Segments
Table 2. Ranking of Global Top Peptide APIs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peptide APIs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Liquid Phase Peptide Synthesis (LPPS)
Table 5. Major Manufacturers of Solid Phase Peptide Synthesis (SPPS)
Table 6. COVID-19 Impact Global Market: (Four Peptide APIs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Peptide APIs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Peptide APIs Players to Combat Covid-19 Impact
Table 11. Global Peptide APIs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Peptide APIs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Peptide APIs Sales by Regions 2015-2020 (K MT)
Table 14. Global Peptide APIs Sales Market Share by Regions (2015-2020)
Table 15. Global Peptide APIs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Peptide APIs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Peptide APIs Sales Share by Manufacturers (2015-2020)
Table 18. Global Peptide APIs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Peptide APIs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide APIs as of 2019)
Table 20. Peptide APIs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Peptide APIs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Peptide APIs Price (2015-2020) (USD/MT)
Table 23. Peptide APIs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Peptide APIs Product Type
Table 25. Date of International Manufacturers Enter into Peptide APIs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Peptide APIs Sales by Type (2015-2020) (K MT)
Table 28. Global Peptide APIs Sales Share by Type (2015-2020)
Table 29. Global Peptide APIs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Peptide APIs Revenue Share by Type (2015-2020)
Table 31. Peptide APIs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Peptide APIs Sales by Application (2015-2020) (K MT)
Table 33. Global Peptide APIs Sales Share by Application (2015-2020)
Table 34. North America Peptide APIs Sales by Country (2015-2020) (K MT)
Table 35. North America Peptide APIs Sales Market Share by Country (2015-2020)
Table 36. North America Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Peptide APIs Revenue Market Share by Country (2015-2020)
Table 38. North America Peptide APIs Sales by Type (2015-2020) (K MT)
Table 39. North America Peptide APIs Sales Market Share by Type (2015-2020)
Table 40. North America Peptide APIs Sales by Application (2015-2020) (K MT)
Table 41. North America Peptide APIs Sales Market Share by Application (2015-2020)
Table 42. Europe Peptide APIs Sales by Country (2015-2020) (K MT)
Table 43. Europe Peptide APIs Sales Market Share by Country (2015-2020)
Table 44. Europe Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Peptide APIs Revenue Market Share by Country (2015-2020)
Table 46. Europe Peptide APIs Sales by Type (2015-2020) (K MT)
Table 47. Europe Peptide APIs Sales Market Share by Type (2015-2020)
Table 48. Europe Peptide APIs Sales by Application (2015-2020) (K MT)
Table 49. Europe Peptide APIs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Peptide APIs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Peptide APIs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Peptide APIs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Peptide APIs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Peptide APIs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Peptide APIs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Peptide APIs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Peptide APIs Sales Market Share by Application (2015-2020)
Table 58. Latin America Peptide APIs Sales by Country (2015-2020) (K MT)
Table 59. Latin America Peptide APIs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Peptide APIs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Peptide APIs Sales by Type (2015-2020) (K MT)
Table 63. Latin America Peptide APIs Sales Market Share by Type (2015-2020)
Table 64. Latin America Peptide APIs Sales by Application (2015-2020) (K MT)
Table 65. Latin America Peptide APIs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Peptide APIs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Peptide APIs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Peptide APIs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Peptide APIs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Peptide APIs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Peptide APIs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Peptide APIs Sales Market Share by Application (2015-2020)
Table 74. CordenPharma Corporation Information
Table 75. CordenPharma Description and Major Businesses
Table 76. CordenPharma Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. CordenPharma Product
Table 78. CordenPharma Recent Development
Table 79. PolyPeptide Corporation Information
Table 80. PolyPeptide Description and Major Businesses
Table 81. PolyPeptide Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. PolyPeptide Product
Table 83. PolyPeptide Recent Development
Table 84. Bachem Corporation Information
Table 85. Bachem Description and Major Businesses
Table 86. Bachem Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bachem Product
Table 88. Bachem Recent Development
Table 89. AmbioPharm Corporation Information
Table 90. AmbioPharm Description and Major Businesses
Table 91. AmbioPharm Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. AmbioPharm Product
Table 93. AmbioPharm Recent Development
Table 94. Pepscan Corporation Information
Table 95. Pepscan Description and Major Businesses
Table 96. Pepscan Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Pepscan Product
Table 98. Pepscan Recent Development
Table 99. BCN Peptides Corporation Information
Table 100. BCN Peptides Description and Major Businesses
Table 101. BCN Peptides Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. BCN Peptides Product
Table 103. BCN Peptides Recent Development
Table 104. Senn Chemicals Corporation Information
Table 105. Senn Chemicals Description and Major Businesses
Table 106. Senn Chemicals Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Senn Chemicals Product
Table 108. Senn Chemicals Recent Development
Table 109. Global Peptide APIs Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Peptide APIs Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Peptide APIs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Peptide APIs Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Peptide APIs Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Peptide APIs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Peptide APIs Players
Table 127. Peptide APIs Customers List
Table 128. Peptide APIs Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Peptide APIs Market Segments
Table 2. Ranking of Global Top Peptide APIs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peptide APIs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Liquid Phase Peptide Synthesis (LPPS)
Table 5. Major Manufacturers of Solid Phase Peptide Synthesis (SPPS)
Table 6. COVID-19 Impact Global Market: (Four Peptide APIs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Peptide APIs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Peptide APIs Players to Combat Covid-19 Impact
Table 11. Global Peptide APIs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Peptide APIs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Peptide APIs Sales by Regions 2015-2020 (K MT)
Table 14. Global Peptide APIs Sales Market Share by Regions (2015-2020)
Table 15. Global Peptide APIs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Peptide APIs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Peptide APIs Sales Share by Manufacturers (2015-2020)
Table 18. Global Peptide APIs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Peptide APIs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide APIs as of 2019)
Table 20. Peptide APIs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Peptide APIs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Peptide APIs Price (2015-2020) (USD/MT)
Table 23. Peptide APIs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Peptide APIs Product Type
Table 25. Date of International Manufacturers Enter into Peptide APIs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Peptide APIs Sales by Type (2015-2020) (K MT)
Table 28. Global Peptide APIs Sales Share by Type (2015-2020)
Table 29. Global Peptide APIs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Peptide APIs Revenue Share by Type (2015-2020)
Table 31. Peptide APIs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Peptide APIs Sales by Application (2015-2020) (K MT)
Table 33. Global Peptide APIs Sales Share by Application (2015-2020)
Table 34. North America Peptide APIs Sales by Country (2015-2020) (K MT)
Table 35. North America Peptide APIs Sales Market Share by Country (2015-2020)
Table 36. North America Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Peptide APIs Revenue Market Share by Country (2015-2020)
Table 38. North America Peptide APIs Sales by Type (2015-2020) (K MT)
Table 39. North America Peptide APIs Sales Market Share by Type (2015-2020)
Table 40. North America Peptide APIs Sales by Application (2015-2020) (K MT)
Table 41. North America Peptide APIs Sales Market Share by Application (2015-2020)
Table 42. Europe Peptide APIs Sales by Country (2015-2020) (K MT)
Table 43. Europe Peptide APIs Sales Market Share by Country (2015-2020)
Table 44. Europe Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Peptide APIs Revenue Market Share by Country (2015-2020)
Table 46. Europe Peptide APIs Sales by Type (2015-2020) (K MT)
Table 47. Europe Peptide APIs Sales Market Share by Type (2015-2020)
Table 48. Europe Peptide APIs Sales by Application (2015-2020) (K MT)
Table 49. Europe Peptide APIs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Peptide APIs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Peptide APIs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Peptide APIs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Peptide APIs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Peptide APIs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Peptide APIs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Peptide APIs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Peptide APIs Sales Market Share by Application (2015-2020)
Table 58. Latin America Peptide APIs Sales by Country (2015-2020) (K MT)
Table 59. Latin America Peptide APIs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Peptide APIs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Peptide APIs Sales by Type (2015-2020) (K MT)
Table 63. Latin America Peptide APIs Sales Market Share by Type (2015-2020)
Table 64. Latin America Peptide APIs Sales by Application (2015-2020) (K MT)
Table 65. Latin America Peptide APIs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Peptide APIs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Peptide APIs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Peptide APIs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Peptide APIs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Peptide APIs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Peptide APIs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Peptide APIs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Peptide APIs Sales Market Share by Application (2015-2020)
Table 74. CordenPharma Corporation Information
Table 75. CordenPharma Description and Major Businesses
Table 76. CordenPharma Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. CordenPharma Product
Table 78. CordenPharma Recent Development
Table 79. PolyPeptide Corporation Information
Table 80. PolyPeptide Description and Major Businesses
Table 81. PolyPeptide Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. PolyPeptide Product
Table 83. PolyPeptide Recent Development
Table 84. Bachem Corporation Information
Table 85. Bachem Description and Major Businesses
Table 86. Bachem Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bachem Product
Table 88. Bachem Recent Development
Table 89. AmbioPharm Corporation Information
Table 90. AmbioPharm Description and Major Businesses
Table 91. AmbioPharm Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. AmbioPharm Product
Table 93. AmbioPharm Recent Development
Table 94. Pepscan Corporation Information
Table 95. Pepscan Description and Major Businesses
Table 96. Pepscan Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Pepscan Product
Table 98. Pepscan Recent Development
Table 99. BCN Peptides Corporation Information
Table 100. BCN Peptides Description and Major Businesses
Table 101. BCN Peptides Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. BCN Peptides Product
Table 103. BCN Peptides Recent Development
Table 104. Senn Chemicals Corporation Information
Table 105. Senn Chemicals Description and Major Businesses
Table 106. Senn Chemicals Peptide APIs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Senn Chemicals Product
Table 108. Senn Chemicals Recent Development
Table 109. Global Peptide APIs Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Peptide APIs Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Peptide APIs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Peptide APIs Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Peptide APIs Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Peptide APIs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Peptide APIs Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Peptide APIs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Peptide APIs Players
Table 127. Peptide APIs Customers List
Table 128. Peptide APIs Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Peptide APIs Product Picture
Figure 2. Global Peptide APIs Sales Market Share by Type in 2020 & 2026
Figure 3. Liquid Phase Peptide Synthesis (LPPS) Product Picture
Figure 4. Solid Phase Peptide Synthesis (SPPS) Product Picture
Figure 5. Global Peptide APIs Sales Market Share by Application in 2020 & 2026
Figure 6. Cancer
Figure 7. Diabetes
Figure 8. Obesity
Figure 9. Fertility
Figure 10. Other
Figure 11. Peptide APIs Report Years Considered
Figure 12. Global Peptide APIs Market Size 2015-2026 (US$ Million)
Figure 13. Global Peptide APIs Sales 2015-2026 (K MT)
Figure 14. Global Peptide APIs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Peptide APIs Sales Market Share by Region (2015-2020)
Figure 16. Global Peptide APIs Sales Market Share by Region in 2019
Figure 17. Global Peptide APIs Revenue Market Share by Region (2015-2020)
Figure 18. Global Peptide APIs Revenue Market Share by Region in 2019
Figure 19. Global Peptide APIs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Peptide APIs Revenue in 2019
Figure 21. Peptide APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Peptide APIs Sales Market Share by Type (2015-2020)
Figure 23. Global Peptide APIs Sales Market Share by Type in 2019
Figure 24. Global Peptide APIs Revenue Market Share by Type (2015-2020)
Figure 25. Global Peptide APIs Revenue Market Share by Type in 2019
Figure 26. Global Peptide APIs Market Share by Price Range (2015-2020)
Figure 27. Global Peptide APIs Sales Market Share by Application (2015-2020)
Figure 28. Global Peptide APIs Sales Market Share by Application in 2019
Figure 29. Global Peptide APIs Revenue Market Share by Application (2015-2020)
Figure 30. Global Peptide APIs Revenue Market Share by Application in 2019
Figure 31. North America Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Peptide APIs Sales Market Share by Country in 2019
Figure 34. North America Peptide APIs Revenue Market Share by Country in 2019
Figure 35. U.S. Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Peptide APIs Market Share by Type in 2019
Figure 40. North America Peptide APIs Market Share by Application in 2019
Figure 41. Europe Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Peptide APIs Sales Market Share by Country in 2019
Figure 44. Europe Peptide APIs Revenue Market Share by Country in 2019
Figure 45. Germany Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Peptide APIs Market Share by Type in 2019
Figure 56. Europe Peptide APIs Market Share by Application in 2019
Figure 57. Asia Pacific Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Peptide APIs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Peptide APIs Revenue Market Share by Region in 2019
Figure 61. China Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Peptide APIs Market Share by Type in 2019
Figure 84. Asia Pacific Peptide APIs Market Share by Application in 2019
Figure 85. Latin America Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Peptide APIs Sales Market Share by Country in 2019
Figure 88. Latin America Peptide APIs Revenue Market Share by Country in 2019
Figure 89. Mexico Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Peptide APIs Market Share by Type in 2019
Figure 96. Latin America Peptide APIs Market Share by Application in 2019
Figure 97. Middle East and Africa Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Peptide APIs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Peptide APIs Revenue Market Share by Country in 2019
Figure 101. Turkey Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Peptide APIs Market Share by Type in 2019
Figure 108. Middle East and Africa Peptide APIs Market Share by Application in 2019
Figure 109. CordenPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bachem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pepscan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. BCN Peptides Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Senn Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Figure 1. Peptide APIs Product Picture
Figure 2. Global Peptide APIs Sales Market Share by Type in 2020 & 2026
Figure 3. Liquid Phase Peptide Synthesis (LPPS) Product Picture
Figure 4. Solid Phase Peptide Synthesis (SPPS) Product Picture
Figure 5. Global Peptide APIs Sales Market Share by Application in 2020 & 2026
Figure 6. Cancer
Figure 7. Diabetes
Figure 8. Obesity
Figure 9. Fertility
Figure 10. Other
Figure 11. Peptide APIs Report Years Considered
Figure 12. Global Peptide APIs Market Size 2015-2026 (US$ Million)
Figure 13. Global Peptide APIs Sales 2015-2026 (K MT)
Figure 14. Global Peptide APIs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Peptide APIs Sales Market Share by Region (2015-2020)
Figure 16. Global Peptide APIs Sales Market Share by Region in 2019
Figure 17. Global Peptide APIs Revenue Market Share by Region (2015-2020)
Figure 18. Global Peptide APIs Revenue Market Share by Region in 2019
Figure 19. Global Peptide APIs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Peptide APIs Revenue in 2019
Figure 21. Peptide APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Peptide APIs Sales Market Share by Type (2015-2020)
Figure 23. Global Peptide APIs Sales Market Share by Type in 2019
Figure 24. Global Peptide APIs Revenue Market Share by Type (2015-2020)
Figure 25. Global Peptide APIs Revenue Market Share by Type in 2019
Figure 26. Global Peptide APIs Market Share by Price Range (2015-2020)
Figure 27. Global Peptide APIs Sales Market Share by Application (2015-2020)
Figure 28. Global Peptide APIs Sales Market Share by Application in 2019
Figure 29. Global Peptide APIs Revenue Market Share by Application (2015-2020)
Figure 30. Global Peptide APIs Revenue Market Share by Application in 2019
Figure 31. North America Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Peptide APIs Sales Market Share by Country in 2019
Figure 34. North America Peptide APIs Revenue Market Share by Country in 2019
Figure 35. U.S. Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Peptide APIs Market Share by Type in 2019
Figure 40. North America Peptide APIs Market Share by Application in 2019
Figure 41. Europe Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Peptide APIs Sales Market Share by Country in 2019
Figure 44. Europe Peptide APIs Revenue Market Share by Country in 2019
Figure 45. Germany Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Peptide APIs Market Share by Type in 2019
Figure 56. Europe Peptide APIs Market Share by Application in 2019
Figure 57. Asia Pacific Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Peptide APIs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Peptide APIs Revenue Market Share by Region in 2019
Figure 61. China Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Peptide APIs Market Share by Type in 2019
Figure 84. Asia Pacific Peptide APIs Market Share by Application in 2019
Figure 85. Latin America Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Peptide APIs Sales Market Share by Country in 2019
Figure 88. Latin America Peptide APIs Revenue Market Share by Country in 2019
Figure 89. Mexico Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Peptide APIs Market Share by Type in 2019
Figure 96. Latin America Peptide APIs Market Share by Application in 2019
Figure 97. Middle East and Africa Peptide APIs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Peptide APIs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Peptide APIs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Peptide APIs Revenue Market Share by Country in 2019
Figure 101. Turkey Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Peptide APIs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Peptide APIs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Peptide APIs Market Share by Type in 2019
Figure 108. Middle East and Africa Peptide APIs Market Share by Application in 2019
Figure 109. CordenPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bachem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pepscan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. BCN Peptides Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Senn Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Peptide APIs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Peptide APIs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
